Preimplantation Genetic Testing Market Trends, Market Growth, and Forecasts (2019-2029)

Aug 29, 2019

Market.us announces publication of its most recently generated research report titled, “Global Preimplantation Genetic Testing Market by Procedure Type (Preimplantation Genetic Screening and Preimplantation Genetic Diagnosis), By End-User (Maternity Centers & Fertility Clinics, Hospitals & Diagnostic Labs, and Research Laboratories & Academic Institutes), and by Region – Global Forecast to 2028.”, Which offers a holistic view of the global Preimplantation Genetic Testing market through systematic segmentation that covers every aspect of the target market.

 

The global Preimplantation Genetic Testing market is projected to be US$ 367.7 Mn in 2018 to reach US$ 763.2 Mn by 2028 at a CAGR of 7.6%.

 

 More On Primepresswire ::

Preimplantation means embryos are tested before being implanted in the uterus. Other types of genetic tests can be done weeks or months later, post-implantation. Preimplantation genetic testing allows physicians to detect defects that are present in embryos and selectively insert healthy embryos in the uterus, which increases the chances of delivering a genetically healthy baby. Preimplantation genetic testing benefits people to evade any hereditary disorders that prevail in the family, which can be carried into the baby.

 

There are three types of preimplantation genetic testing (PGT, previously known as PGD or preimplantation genetic diagnosis). These methods include a) PGT-M: Preimplantation genetic testing for monogenic (single-gene) disorders b) PGT-SR: Preimplantation genetic testing for structural rearrangement c) PGT-A: Preimplantation genetic testing for aneuploidy. All require in-vitro fertilization (IVF); biopsy of an embryo, or less commonly polar bodies (I and II) for genetic testing and post which transfer of selected fresh or frozen-thawed embryos into the uterus is done, based on the results of genetic testing.

 


    Preimplantation genetic testing depends on the fact that all of the embryo’s cells comprise the same genetic information. Preimplantation genetic testing is carried out when a fertilized egg has separated enough times to make an embryo with at least eight cells.

    The global preimplantation genetic testing market is expected to observe high growth over the period, due to the increasing number of people seeking IVF treatment for fertility related problems and growing awareness of preimplantation genetic testing for evading birth defects among babies. Increasing acceptance of preimplantation genetic testing in developed and emerging countries is projected to create healthy growth prospects for the market contributors in the global preimplantation genetic testing market.

     

    Global Preimplantation Genetic Testing Market Key Segments

    Type

    • Preimplantation Genetic Screening, 
    • Preimplantation Genetic Diagnosis

     

    Application

    • Maternity Centers & Fertility Clinics, Hospitals, Diagnostic Labs, and Service Providers, Research Laboratories & Academic Institutes

     

    Key Market Players included in the report:

    • Thermo Fisher Scientific Inc., 
    • Perkin, Elmer Inc., 
    • Abbott Laboratories, 
    • Yikon Genomics Co.Ltd., 
    • Illumina Inc., Agilent Technologies Inc., 
    • The Cooper Companies Inc. (CooperSurgical), 
    • Natera Inc

     

    To get more details about Global Preimplantation Genetic Testing Market, Visit: https://market.us/report/preimplantation-genetic-testing-market/

     

    Blog: https://biznewsmedia.com